Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Clinical trial NCT01899326 · TERMINATED

Trial details

NCT number: NCT01899326
Sponsor: Albert Einstein College of Medicine
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

DS (Durie/Salmon) Stage I Plasma Cell Myeloma DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Start date: 2013-09-01
Primary completion: 2015-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.